Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angiometrx Inc. was a Canadian medical device company that developed the Metricath System, a specialized balloon catheter technology for intravascular measurement. The Metricath device allowed clinicians to accurately measure the diameter and cross-sectional area of arteries and stents during interventional procedures, providing an alternative to intravascular ultrasound (IVUS). Founded in the late 1990s and based in Richmond, British Columbia, the company was acquired by Medical Ventures Corp (later Neovasc Inc.) in 2003. Although the Metricath System received FDA clearance and was marketed globally, Neovasc discontinued the product line in 2009 to focus on other cardiovascular technologies. Angiometrx was officially amalgamated into Neovasc Medical Inc. in 2015.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angiometrx.